Clinical Trials Directory

Trials / Unknown

UnknownNCT03123926

Spontaneous Preterm Birth Marker Test

Spontaneous Preterm Birth Marker Test (SPBMT): Preterm Prediction Prospective Study

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Sprim Advanced Life Sciences · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The prediction of preterm birth is beneficial because it initiates early treatment to minimize risk. It defines a population at risk to provide particular treatment and may lead us to a better understanding the mechanisms of preterm birth. The understanding of the mechanisms and etiology consequently leads to the possibility of early intervention and effective management aiming at preventing preterm birth. Five most common interventions for preventing and treating preterm birth are antibiotics, cervical cerclage, bed rest, progesterone, and tocolytic therapy. However, there are insufficient evidence showing the efficacy of cerclage and bed rest; antibiotics may only delay but not prevent the preterm birth; the use of certain tocolytics needs to be considered against the possible adverse effects. The early detection of pregnant women with high risk for preterm delivery would be the ideal solution to prevent preterm birth. However, to date, there is inadequate literature and little knowledge of diagnosis, treatment, prevention and prediction of preterm birth.

Conditions

Timeline

Start date
2016-11-01
Primary completion
2017-12-01
Completion
2018-12-01
First posted
2017-04-21
Last updated
2017-04-21

Locations

1 site across 1 country: Philippines

Source: ClinicalTrials.gov record NCT03123926. Inclusion in this directory is not an endorsement.